Das Klinikum

Prof. Dr. med. Jörg Henes

Prof. Dr. med. Jörg Henes

Oberarzt

Leiter des Bereichs Rheumatologie, Oberarzt der Abteilung Medizinische Klinik II

Ärztlicher Leiter des Zentrums für Interdisziplinäre Klinische Immunologie, Rheumatologie und Autoimmunerkrankungen (INDIRA)

Sprecher des Rheumazentrums Württemberg und des Vaskulitiszentrums Süd

Kontakt

Telefonnummer: 07071 29-82726

Faxnummer: +49-7071-2925085

E-Mail-Adresse: joerg.henes@med.uni-tuebingen.de

Klinik / Institut / Zentrum

  • Facharzt für den Schwerpunkt Innere Medizin/Rheumatologie
  • Systemische Sklerose
  • Autologe Stammzelltransplantation und andere zelluläre Therapien (z.B. CART-Zellen) bei schweren Autoimmunerkrankungen
  • Schwangerschaft bei Rheumatischen Erkrankungen
  • Familiäres Mittelmeerfieber
  • Interdiszipilinäre Rheumatologie
  • Großgefäßvaskulitiden
  • Systemische Sklerose oder Sklerodermie; Pathomechanismen, klinische Manifestationen und neue Therapieoptionen
  • Autologe Stammzelltransplantation und andere Zelluläre RTherapien (z.B. CART-Zell-Therapien) bei schweren Autoimmunerkrankungen, V.a. der Systemischen Sklerose
  • Fertilität, Sexualität, Kinderwunsch und Schwangerschaft bei Rheumatischen Erkrankungen
  • Autoinflammatorische Erkrankungen, insbesondere Familiäres Mittelmeerfieber
  • Großgefäßvaskulitiden, insbesondere Bildgebung und Therapie
  • Personalisierte Medizin in der Rheumatolgie
    Interdisziplinäre Optimierung der Patientenversorgung
  • 10/1998 - 12/2004Studium der Humamedizin an der Eberhard-Karls-Universität zu Tübingen
  • Seit 01.20.2005Arzt an der Universitätsklinik Tübingen; Medizinische Klinik II
  • Seit 03/2012Oberarzt der Medizinischen Klinik II und Leiter des Bereichs Rheumatologie
  • 21.04.2015Habilitation im Fach Innere Medizin/Rheumatologie; Thema: Autologe Stammzelltransplantation bei Systemischer Sklerose
  • Seit 2014Leiter des Zentrums für Interdisziplinäre Klinische Immunologie, Rheumatologie und Autoimmunerkrankungen (INDIRA)
  • 11/2014Gründung des Vaskulitiszentrums Süd
  • Seit 21.02.2018Außerplanmäßiger Professor der Universität Tübingen
  • Seit 2021Sprecher des Molekularen Entzündungsboards des Zentrums für Personalisierte Medizin Inflammation
  • 10/2021Schwerpunkbezeichnung klinische Immunologie
  • Forschungspreis der Firma Pfizer zum Thema: Prävalenz der Psoriasis Arthritis bei Patienten mit Psoriasis
  • Forschungsförderung der Deutschen Gesellschaft für Rheumatologie; Thema: The functional role of tolerogenic iNKT cells for the pathogenesis of systemic sclerosis
  • Mehrfach unter den besten 25 Lehrenden im Lehrmarathon
  • IKLIC Rheumatologie mehrfach unter den besten Lehrveranstaltungen
  • FOCUS Ärzteliste seit 2018, Rheumatologie
  • Ärzeliste Guter Rat, Rheumatologie
  • Stern Liste: Deutschlands ausgezeichnete Ärzte; Rheumatologie
  • Older age onset of systemic sclerosis - accelerated disease progression in all disease subsets. Rheumatology (Oxford). 2020 Apr 24. pii: keaa127. doi: 10.1093/rheumatology/keaa127
  • [Autologous hematopoietic stem cell transplantation for systemic sclerosis : Position statement of the stem cell therapy working party of the German Society of Rheumatology]
  • Autologous hematopoietic stem cell transplantation with reduced-intensity conditioning regimens in refractory Takayasu arteritis: a retrospective multicenter case-series from the Autoimmune Diseases Working Party (ADWP) of the European Society for Blood and Marrow Transplantation (EBMT). Bone Marrow Transplant. 2020 Apr 22. doi: 10.1038/s41409-020-0907-4
  • Sexual function in German women with systemic sclerosis compared to women with systemic lupus erythematosus and evaluation of a screening test. Clin Exp Rheumatol. 2020 Apr 14. [Epub ahead of print]
  • Monocyte-derived dendritic cells display a highly activated phenotype and altered function in patients with familial Mediterranean fever
  • Inhibition of effector B cells by ibrutinib in systemic sclerosis. Arthritis Res Ther. 2020 Mar 30;22(1):66. doi: 10.1186/s13075-020-02153-8
  • Autologous stem cell transplantation for progressive systemic sclerosis: a prospective non-interventional study from the European Society for Blood and Marrow Transplantation Autoimmune Disease Working Party. Haematologica January 2020: haematol.2019.230128; doi:10.3324/haematol.2019.230128
  • Effect of topical rosemary essential oil on Raynaud phenomenon in systemic sclerosis.Complement Ther Med. 2018 Oct;40:191-194
  • Chest CT texture analysis for response assessment in systemic sclerosis. Eur J Radiol. 2018 Apr;101:50-58
  • Imaging giant cell arteritis and Aortitis in contrast enhanced 18F-FDG PET/CT: Which imaging score correlates best with laboratory inflammation markers? Eur J Radiol. 2018 Feb;99:94-102
  • Molecular recognition patterns of anti-topoisomerase I-antibodies in patients with systemic sclerosis before and after autologous stem cell transplantation. Clin Exp Rheumatol. 2018 Feb 13
  • Mapping and predicting mortality from systemic sclerosis. Ann Rheum Dis. 2017 Nov;76(11):1897-1905
  • Comprehensive metabolic and morphologic disease characterization in systemic sclerosis: initial results using combined positron emission tomography and magnetic resonance imaging. Q J Nucl Med Mol Imaging. 2017 May 3
  • Treatment of familial Mediterranean fever with anakinra in patients unresponsive to colchicine. Scand J Rheumatol. 2017 Sep;46(5):407-409 2017
  • Thymic findings before and after autologous stem cell transplantation for severe systemic sclerosis: a retrospective study using computed tomography in the pre- and post-transplantation setting. Clin Exp Rheumatol. 2017 May-Jun;35 Suppl 104(2):11-12
  • BMonitoring Disease Activity in Patients with Aortitis and Chronic Periaortitis Undergoing Immunosuppressive Therapy by Perfusion CT. Acad Radiol. 2017 Apr;24(4):470-477
  • Analysis of anti-topoisomerase I antibodies in patients with systemic sclerosis before and after autologous stem cell transplantation. Rheumatology (Oxford). 2017 Mar 1;56(3):451-456. 2017
  • Cardiovascular magnetic resonance patterns of biopsy proven cardiac involvement in systemic sclerosis. J Cardiovasc Magn Reson. 2016 Oct 21;18(1):70
  • Henes M, Rall K, Igney-Oertel A, Taran FA, Brucker S, Henes JC Anti-Müllerian hormone levels are not reduced in patients with adult autoinflammatory diseases compared to healthy controls. Scand J Rheumatol. 2016 Sep 16:1-2
  • Kloth C, Maximilian Thaiss W, Preibsch H, Mark K, Kötter I, Hetzel J, Nikolaou K, Henes J*, Horger M*. Quantitative chest computed tomography analysis in patients with systemic sclerosis before and after autologous stem cell transplantation: comparison of results with those of pulmonary function tests and clinical tests. Rheumatology (Oxford). 2016 Oct;55(10):1763-70
  • Oliveira MC, Labopin M, Henes J, Moore J, Papa ND, Cras A, Sakellari I, Schroers R, Scherer HU, Cuneo A, Kyrcz-Krzemien S, Daikeler T, Alexander T, Finke J, Badoglio M, Simões B, Snowden JA, Farge D. Does ex vivo CD34+ positive selection influence outcome after autologous hematopoietic stem cell transplantation in systemic sclerosis patients? Bone Marrow Transplant. 2016 Apr;51(4):501-5 2016
  • Bier G, Henes J, Eulenbruch C, Xenitidis T, Nikolaou K, Horger M Perfusion-based assessment of disease activity in untreated and treated patients with aortitis and chronic periaortitis: correlation with CT-morphological, clinical and serological data. Br J Radiol. 2015 Dec;88(1056):20150526
  • Mueller KA, Mueller II, Eppler D, Zuern CS, Seizer P, Kramer U, Koetter I, Roecken M, Kandolf R, Gawaz M, Geisler T, Henes JC*, Klingel K* Clinical and histopathological features of patients with systemic sclerosis undergoing endomyocardial biopsy. PLoS One. 2015 May 12;10(5):e0126707
  • Henes M, Froeschlin J, Taran FA, Brucker S, Rall KK, Xenitidis T, Igney-Oertel A, Lawrenz B, Henes JC. Ovarian reserve alterations in premenopausal women with chronic inflammatory rheumatic diseases: impact of rheumatoid arthritis, Behçet's disease and spondyloarthritis on anti-Müllerian hormone levels. Rheumatology (Oxford). 2015 Sep;54(9):1709-12
  • Kiefer-Schmidt I, Lim M, Preissl H, Draganova R, Weiss M, Abele H, Kagan K, Henes J Fetal magnetocardiography (fMCG) to monitor cardiac time intervals in fetuses at risk for isoimmune AV block. Lupus. 2014 Aug;23(9):919-25
  • Wacker-Gussmann A, Paulsen H, Stingl K, Braendle J, Goelz R, Henes J Aterioventricular conduction delay in the second trimester measured by fetal magnetocardiography Journal of Immunology Research (formerly titled Clinical and Developmental Immunology J Immunol Res. 2014;2014:753953
  • Henes JC, Koetter I, Horger M, Schmalzing M, Mueller K, Eick C, Bauer A, Vogel W, Kanz L Autologous stem cell transplantation with a thiotepa-based conditioning in patients with systemic sclerosis and cardiac manifestations. Rheumatology (Oxford). 2014 May;53(5):919-22
  • Henes JC, Ziupa E, Eisfelder M, Adamczyk A, Knaudt B, Jacobs F, Lux J, Schanz S, Fierlbeck G, Spira D, Horger M, Kanz L, Koetter I. High prevalence of psoriatic arthritis in dermatological patients with psoriasis: a cross-sectional study Rheumatol Int. 2014 Feb;34(2):227-34
  • Henes JC, Horger M, Amberger C, Schmalzing M, Fierlbeck G, Kanz L, Koetter I. Enteric-coated mycophenolate sodium for progressive systemic sclerosis-a prospective open-label study with CT histography for monitoring of pulmonary fibrosis. Clin Rheumatol. 2013 May;32(5):673-8
  • Schanz S, Henes J, Ulmer A, Kötter I, Fierlbeck G, Claussen CD, Horger M Magnetic resonance imaging findings in patients with systemic scleroderma and musculoskeletal symptoms Eur Radiol. 2013 Jan;23(1):212-21 2012
  • Loock J, Henes J, Kötter I, Witte T, Lamprecht P, Schirmer M, Gross WL Treatment of refractory giant cell arteritis with cyclophosphamide:a retrospective analysis of 35 patients from three centres. Clin Exp Rheumatol. 2012 Jan-Feb;30(1 Suppl 70):S70-6
  • Henes JC, Henes M, von Wolff M, Schmalzing M, Kötter I, Lawrenz B Fertility preservation in women with vasculitis: experiences from the FertiPROTEKT network. Clin Exp Rheumatol. 2012 Jan-Feb;30(1 Suppl 70):S53-6
  • Henes M*, Henes JC*, Neunhoeffer E, Schmalzing M, von Wolff M, Kötter I, Lawrenz B. Fertility preservation methods in young women with systemic lupus erythematosus prior to cytotoxic therapy - Experiences from the FertiProtekt network. Lupus. 2012 Aug;21(9):953-8
  • Henes JC, Schmalzing M, Vogel W, Riemekasten G, Fend F, Kanz L, Koetter I. Optimization of Autologous Stem Cell Transplantation for Systemic Sclerosis - A Single-center Longterm Experience in 26 Patients with Severe Organ Manifestations. J Rheumatol. 2012 Feb;39(2):269-75
  • Lawrenz B*, Henes JC*, Henes M, Neunhoeffer E, Schmalzing M, Fehm T, Kötter I Impact of systemic lupus erythematosus on ovarian reserve in premenopausal women - evaluation by using Anti-Muellerian hormone. Lupus. 2011 Oct;20(11):1193-7
  • Daikeler T, Labopin M, Di Gioia M, Abinun M, Alexander T, Miniati I, Gualandi F, Fassas A, Martin T, Schwarze CP, Wulffraat N, Buch M, Sampol A, Carreras E, Dubois B, Gruhn B, Güngör T, Pohlreich D, Schuerwegh A, Snarski E, Snowden J, Veys P, Fasth A, Lenhoff S, Messina C, Voswinkel J, Badoglio M, Henes J, Launay D, Tyndall A, Gluckman E, Farge D. Secondary autoimmune diseases occurring after HSCT for an autoimmune disease: a retrospective study of the EBMT Autoimmune Disease Working Party. Blood. 2011 Aug 11;118(6):1693-8
  • Henes JC, Mueller M, Pfannenberg C, Kanz L, Koetter I Cyclophosphamide for large vessel vasculitis: assessment of response by PET/CT. Clin Exp Rheumatol. 2011 Jan-Feb;29(1 Suppl 64):S43-8
  • Henes, JC, Müller M, Krieger J, Balletshofer B, Pfannenberg AC, Kanz L, Kötter I [18F] FDG-PET/CT as a new and sensitive imaging method for the diagnosis of large vessel vasculitis Clin Exp Rheumatol; 26(3 Suppl 49):S47-52
  • Henes, JC; Richter, C; Kanz, L; Koetter, I. B-cell depletion in patients with rheumatoid arthritis refractant to multiple TNF blockers and the interleukin 1 receptor-antagonist anakinra: Good responses in an extreme negative selection Rheumatology International; 28(1):33-7
  • Fritz J, Henes JC, Thomas C, Clasen S, Fenchel M, Claussen CD, Lewin JS, Pereira PL Diagnostic and interventional MRI of the sacroiliac joints using a 1.5-T open-bore magnet: a one-stop-shopping approach. AJR Am J Roentgenol. 191(6):1717-24
  • Henes JC, Schedel J, Kanz L, Koetter I Rituximab and concomitant leflunomide for the treatment of rheumatoid arthritis. Rheumatol Int; 30(5):709-12.
  • Henes JC, Kanz L, Koetter I Rituximab and leflunomide for Wegener's granulomatosis: a long-term follow-up. Rheumatol Int; 31(3):425-6
  • Henes M*, Henes JC*, Schmalzing M, Neuenhoeffer E, Rothmund R, Kötter I, Lawrenz B [Fertility preservation for young patients with autoimmune diseases and the need for cytotoxic treatment - Clinical experiences] Z Rheumatol; 70(2):146-53
  • Publikationen
  • Systemsklerose Workshop mit Patientenveranstaltung alle 2 Jahre
  • INDIRA Jahressymposium; 1 x Jahr
  • Jahressymposium des Vaskulitiszentrums Süd
  • Vorlesung Innere Medizin/Rheumatologie
  • IKLIC Rheumatologie; 6. Semester
  • Tü-REX Pate
  • PJ Unterricht Rheumatologie
  • Deutsche Gesellschaft für Rheumatologie (DGRH)
  • Deutsches Netzwerk Systemische Sklerose (DNSS)
  • European Scleroderma Trials and Research group (EUSTAR)
  • European Society for Blood and Marrow Transplantation (EBMT)